Sarepta (SRPT) sinks 40% on Elevidys safety halt, while Sage Therapeutics (SAGE) soars on $12 cash-plus-CVR buyout by Supernus (SUPN).
Jun 16, 2025
We don’t cover fluff. We cover ideas that move portfolios. Upgrade now, before you miss your next trade
Upgrade